Segment Disclosures - Schedule of Information for the Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	$ 702,889	$ 606,560
Plus: Adjustments to NOI	26,918	27,562
Interest income and other	15,821	5,751
Interest expense	(72,693)	(60,907)
Depreciation and amortization	(268,546)	(219,219)
General and administrative	(26,118)	(23,299)
Transaction and merger-related costs	(5,534)	(107,220)
Impairments and loan loss reserves, net	3,562	(11,458)
Gain (loss) on sales of real estate, net	0	3,255
Other income (expense), net	(6,126)	78,516
Less: Healthpeak’s share of unconsolidated joint venture Adjusted NOI	(5,399)	(5,193)
Plus: Noncontrolling interests’ share of consolidated joint venture Adjusted NOI	7,195	6,566
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	54,291	22,499
Outpatient Medical
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net		3,000
Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	687,068	600,809
Healthpeak’s share of unconsolidated joint venture total revenues	10,059	7,600
Noncontrolling interests’ share of consolidated joint venture total revenues	(9,973)	(9,039)
Operating expenses	(273,143)	(243,729)
Healthpeak’s share of unconsolidated joint venture operating expenses	(4,660)	(2,407)
Noncontrolling interests’ share of consolidated joint venture operating expenses	2,778	2,473
Adjustments to NOI	(26,918)	(27,562)
Adjusted NOI for reportable segments	385,211	328,145
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures	54,291	22,499
Operating Segment | Outpatient Medical
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	320,548	238,272
Healthpeak’s share of unconsolidated joint venture total revenues	7,259	2,739
Noncontrolling interests’ share of consolidated joint venture total revenues	(9,973)	(8,876)
Operating expenses	(105,225)	(81,268)
Healthpeak’s share of unconsolidated joint venture operating expenses	(2,994)	(1,083)
Noncontrolling interests’ share of consolidated joint venture operating expenses	2,778	2,430
Adjustments to NOI	(12,082)	(6,127)
Adjusted NOI for reportable segments	200,311	146,087
Operating Segment | Lab
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	217,593	223,761
Healthpeak’s share of unconsolidated joint venture total revenues	2,800	4,861
Noncontrolling interests’ share of consolidated joint venture total revenues	0	(163)
Operating expenses	(57,658)	(56,840)
Healthpeak’s share of unconsolidated joint venture operating expenses	(1,666)	(1,324)
Noncontrolling interests’ share of consolidated joint venture operating expenses	0	43
Adjustments to NOI	(14,836)	(21,435)
Adjusted NOI for reportable segments	146,233	148,903
Operating Segment | CCRC
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues	148,927	138,776
Healthpeak’s share of unconsolidated joint venture total revenues	0	0
Noncontrolling interests’ share of consolidated joint venture total revenues	0	0
Operating expenses	(110,260)	(105,621)
Healthpeak’s share of unconsolidated joint venture operating expenses	0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses	0	0
Adjustments to NOI	0	0
Adjusted NOI for reportable segments	$ 38,667	$ 33,155